Trastuzumab in pregnancy associated with poor fetal outcome

Ann Oncol. 2008 Jan;19(1):191-2. doi: 10.1093/annonc/mdm542. Epub 2007 Dec 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / surgery
  • Capillary Leak Syndrome / etiology*
  • Carcinoma, Lobular / drug therapy
  • Carcinoma, Lobular / secondary
  • Carcinoma, Lobular / surgery
  • Enterocolitis, Necrotizing / etiology
  • Fatal Outcome
  • Female
  • Fetus / drug effects*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / etiology*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Oligohydramnios / chemically induced*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Respiratory Distress Syndrome, Newborn / etiology*
  • Trastuzumab
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vinorelbine

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Vinblastine
  • Trastuzumab
  • Vinorelbine